Pamuk Omer Nuri, Yeşil Yusuf, Cakir Necati
Department of Rheumatology, Trakya University Medical Faculty, Edirne, Turkey.
Semin Arthritis Rheum. 2006 Oct;36(2):130-4. doi: 10.1016/j.semarthrit.2006.05.002. Epub 2006 Jul 13.
This study aims to compare fibromyalgia (FM) and chronic widespread pain (CWP) patients who do not fulfill the criteria for tender points (TP).
We included 150 patients diagnosed with FM according to ACR 1990 criteria and 42 patients with CWP who did not fulfill TP criteria for FM into the study. The clinical features of the patients were recorded, and the TP count was determined. By means of a visual analog scale (VAS), all patients were questioned about the severity of pain and FM-related symptoms. In addition, the patients were administered the Duke Anxiety Depression (Duke-AD) scale and somatization symptom questionnaire. Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale was used to determine the neuropathic pain score.
According to VAS, the severity of pain, sleep disturbance, the number of somatization symptoms, LANSS, and Duke-AD scores were significantly higher in FM patients than in patients with CWP (all P values <0.05). The number of TP correlated with severity of pain (r = 0.32, P < 0.001), the number of somatization symptoms (r = 0.26, P = 0.01), sleep disturbance (r = 0.18, P = 0.01), and LANSS score (r = 0.4, P < 0.001). Multiple logistic regression analysis revealed that independent factors that affected the presence of > or =11 TP were the severity of pain on VAS (OR: 1.03, 95% CI: 1.01-1.06, P = 0.045) and LANSS score (OR: 1.36, 95% CI: 1.12-1.62, P = 0.001).
CWP patients have symptoms similar to FM patients, though less severe. The most important factor that affects the criteria for fulfilling the number TP in CWP patients is the neuropathic pain score, which suggests that FM is primarily a neuropathic pain syndrome.
本研究旨在比较未满足压痛点(TP)标准的纤维肌痛(FM)患者和慢性广泛性疼痛(CWP)患者。
我们将150例根据美国风湿病学会(ACR)1990年标准诊断为FM的患者和42例未满足FM的TP标准的CWP患者纳入研究。记录患者的临床特征,并确定TP计数。通过视觉模拟量表(VAS),询问所有患者疼痛的严重程度和FM相关症状。此外,对患者进行杜克焦虑抑郁量表(Duke-AD)和躯体化症状问卷评估。使用利兹神经病理性症状和体征评估(LANSS)疼痛量表确定神经病理性疼痛评分。
根据VAS,FM患者的疼痛严重程度、睡眠障碍、躯体化症状数量、LANSS和Duke-AD评分显著高于CWP患者(所有P值<0.05)。TP数量与疼痛严重程度(r = 0.32,P < 0.001)、躯体化症状数量(r = 0.26,P = 0.01)、睡眠障碍(r = 0.18,P = 0.01)和LANSS评分(r = 0.4,P < 0.001)相关。多因素逻辑回归分析显示,影响存在≥11个TP的独立因素是VAS上的疼痛严重程度(OR:1.03,95%CI:1.01 - 1.06,P = 0.045)和LANSS评分(OR:1.36,95%CI:1.12 - 1.62,P = 0.001)。
CWP患者具有与FM患者相似的症状,尽管症状较轻。影响CWP患者满足TP数量标准的最重要因素是神经病理性疼痛评分,这表明FM主要是一种神经病理性疼痛综合征。